Science News
from research organizations

Researchers create compounds that boost antibiotics' effectiveness

Date:
November 25, 2013
Source:
University of California - Irvine
Summary:
Inhibitor compounds developed by biologists and chemists have been shown to bolster the ability of antibiotics to treat deadly bacterial diseases such as MRSA and anthrax.
Share:
       
FULL STORY

Inhibitor compounds developed by UC Irvine structural biologists and Northwestern University chemists have been shown to bolster the ability of antibiotics to treat deadly bacterial diseases such as MRSA and anthrax.

The discovery by UC Irvine's Thomas Poulos and Northwestern's Richard Silverman builds on previous work in which they created compounds that inhibit an enzyme called neuronal nitric oxide synthase. These have demonstrated the potential to treat neurodegenerative diseases by blocking overproduction of cell-killing nitric oxide within neurons.

Now the researchers are learning that the compounds may have another important function. After Poulos and Silverman read a study suggesting that nitric oxide synthase helped pathogenic bacteria resist antibiotics, their laboratory teams paired the inhibitor compounds with currently used antibiotics to see if they could suppress NOS -- and increase the antibiotics' effectiveness.

"We found that NOS inhibitors were extremely successful at inhibiting neurodegeneration in an animal model, and if they could be successful combating other diseases, we wanted to identify that as quickly as possible to help other people," said Poulos, Chancellor's Professor of biochemistry, chemistry and pharmaceutical sciences at UC Irvine.

The researchers tested their compounds on Bacillus subtilis, nonpathogenic bacteria very similar to Staphylococcus aureus (known as MRSA), and Bacillus anthracis, which causes anthrax. Bacteria treated with the NOS inhibitors and an antibiotic were killed off more efficiently and completely than bacteria treated with only an antibiotic. The scientists then compared the three-dimensional structure of the inhibitors bound to the bacterial NOS with those bound to the neuronal NOS and determined that they bonded quite differently.

"Now that we know which region of the NOS to target, we should to be able to develop compounds that selectively bind to bacterial NOS," Poulos said, adding that his team will also need to try out those compounds in animal models.


Story Source:

The above story is based on materials provided by University of California - Irvine. Note: Materials may be edited for content and length.


Journal Reference:

  1. J. K. Holden, H. Li, Q. Jing, S. Kang, J. Richo, R. B. Silverman, T. L. Poulos. Structural and biological studies on bacterial nitric oxide synthase inhibitors. Proceedings of the National Academy of Sciences, 2013; 110 (45): 18127 DOI: 10.1073/pnas.1314080110

Cite This Page:

University of California - Irvine. "Researchers create compounds that boost antibiotics' effectiveness." ScienceDaily. ScienceDaily, 25 November 2013. <www.sciencedaily.com/releases/2013/11/131125125447.htm>.
University of California - Irvine. (2013, November 25). Researchers create compounds that boost antibiotics' effectiveness. ScienceDaily. Retrieved May 27, 2015 from www.sciencedaily.com/releases/2013/11/131125125447.htm
University of California - Irvine. "Researchers create compounds that boost antibiotics' effectiveness." ScienceDaily. www.sciencedaily.com/releases/2013/11/131125125447.htm (accessed May 27, 2015).

Share This Page: